Stockreport

Nektar Therapeutics Sees Something In The Data And Puts Its Drug To The Test [Seeking Alpha]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF The phase 1b data in atopic dermatitis show promise, and a 400-patient phase 2 study in that indication will allow NKTR to examine if the drug indeed has value. I giv [Read more]